- Home
- NSPR vs RPTX Comparison
NSPR vs RPTX Comparison
Compare NSPR & RPTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NSPR
- RPTX
- Stock Information
- Founded
- NSPR 2005
- RPTX 2016
- Country
- NSPR United States
- RPTX Canada
- Employees
- NSPR N/A
- RPTX N/A
- Industry
- NSPR Medical/Dental Instruments
- RPTX Biotechnology: Pharmaceutical Preparations
- Sector
- NSPR Health Care
- RPTX Health Care
- Exchange
- NSPR Nasdaq
- RPTX Nasdaq
- Market Cap
- NSPR 75.1M
- RPTX 63.9M
- IPO Year
- NSPR N/A
- RPTX 2020
- Fundamental
- Price
- NSPR $2.44
- RPTX $1.54
- Analyst Decision
- NSPR Strong Buy
- RPTX Strong Buy
- Analyst Count
- NSPR 2
- RPTX 3
- Target Price
- NSPR $4.50
- RPTX $4.50
- AVG Volume (30 Days)
- NSPR 386.2K
- RPTX 95.8K
- Earning Date
- NSPR 08-05-2025
- RPTX 08-05-2025
- Dividend Yield
- NSPR N/A
- RPTX N/A
- EPS Growth
- NSPR N/A
- RPTX N/A
- EPS
- NSPR N/A
- RPTX N/A
- Revenue
- NSPR $7,027,000.00
- RPTX $1,073,000.00
- Revenue This Year
- NSPR $4.85
- RPTX N/A
- Revenue Next Year
- NSPR $113.47
- RPTX N/A
- P/E Ratio
- NSPR N/A
- RPTX N/A
- Revenue Growth
- NSPR 8.49
- RPTX N/A
- 52 Week Low
- NSPR $1.99
- RPTX $0.89
- 52 Week High
- NSPR $3.80
- RPTX $4.29
- Technical
- Relative Strength Index (RSI)
- NSPR 54.16
- RPTX 65.29
- Support Level
- NSPR $2.12
- RPTX $1.40
- Resistance Level
- NSPR $2.46
- RPTX $1.59
- Average True Range (ATR)
- NSPR 0.16
- RPTX 0.05
- MACD
- NSPR 0.01
- RPTX 0.01
- Stochastic Oscillator
- NSPR 73.33
- RPTX 81.82
About NSPR InspireMD Inc.
InspireMD Inc is a United States based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System (MGuard Prime EPS). It generates the majority of the revenue from the sales of CGuard EPS which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The group operates in Italy, Germany, Russia and other countries.
About RPTX Repare Therapeutics Inc.
Repare Therapeutics Inc is a precision medicine oncology company focused on the development of synthetic lethality-based therapies for patients with cancer. The Company's focus is the research, development and commercialization of precision oncology drugs targeting specific vulnerabilities of tumors in genetically defined patient populations.